Home
About
Overview
Sharing Data
ORCID
Help
History (5)
ACR Appropriateness Criteria on percutaneous catheter drainage of infected fluid collections.
Computer-aided diagnosis in chest radiology.
Cutting Edge: Engineering Active IKKß in T Cells Drives Tumor Rejection.
The effects of 17ß-estradiol and a selective estrogen receptor modulator, bazedoxifene, on ovarian carcinogenesis.
Treatment of Cancer with Radio-Immunotherapy: What We Currently Know and What the Future May Hold.
See All 5 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Treatment of Cancer with Radio-Immunotherapy: What We Currently Know and What the Future May Hold.
Treatment of Cancer with Radio-Immunotherapy: What We Currently Know and What the Future May Hold. Int J Mol Sci. 2021 Sep 03; 22(17).
View in:
PubMed
subject areas
Humans
Neoplasm Metastasis
Neoplasms
Radioimmunotherapy
authors with profiles
Ralph R. Weichselbaum
Sean Pitroda